BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30483877)

  • 1. The role of PI3K/AKT/FOXO signaling in psoriasis.
    Zhang M; Zhang X
    Arch Dermatol Res; 2019 Mar; 311(2):83-91. PubMed ID: 30483877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
    Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S
    Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway.
    Wang R; Wang FF; Cao HW; Yang JY
    Life Sci; 2019 Aug; 230():28-34. PubMed ID: 31108094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/PTEN signaling in angiogenesis and tumorigenesis.
    Jiang BH; Liu LZ
    Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.
    Gravina GL; Mancini A; Scarsella L; Colapietro A; Jitariuc A; Vitale F; Marampon F; Ricevuto E; Festuccia C
    Tumour Biol; 2016 Jan; 37(1):341-51. PubMed ID: 26219891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
    Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO
    Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of PTEN expression in psoriatic lesions.
    Li Y; Man X; You L; Xiang Q; Li H; Xu B; Chen Z; Zhang X; Lian S
    Int J Dermatol; 2014 Jul; 53(7):855-60. PubMed ID: 24168180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt, FoxO and regulation of apoptosis.
    Zhang X; Tang N; Hadden TJ; Rishi AK
    Biochim Biophys Acta; 2011 Nov; 1813(11):1978-86. PubMed ID: 21440011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
    Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
    Beck JT; Ismail A; Tolomeo C
    Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/Akt/FoxO: a novel participant in signal transduction in bone cells under mechanical stimulation.
    Ma Y; Wang H
    Cell Biol Int; 2012 Oct; 36(10):923-6. PubMed ID: 22716317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
    J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.